Ironwood Pharmaceuticals Inc., of Cambridge, Mass., reported U.S. net sales of constipation drug Linzess (linaclotide), as reported by partner Allergan plc, of Dublin, totaling $190.9 million for the third quarter, up 16 percent over the third quarter in 2016.